Avita Medical Ltd (RCEL) - Total Liabilities

Latest as of December 2025: $73.04 Million USD

Based on the latest financial reports, Avita Medical Ltd (RCEL) has total liabilities worth $73.04 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Avita Medical Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.

Avita Medical Ltd - Total Liabilities Trend (1993–2025)

This chart illustrates how Avita Medical Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Avita Medical Ltd balance sheet assets.

Avita Medical Ltd Competitors by Total Liabilities

The table below lists competitors of Avita Medical Ltd ranked by their total liabilities.

Company Country Total Liabilities
COMMERCIAL SYN BAGS ORD (BSE)
NSE:COMSYN
India Rs1.53 Billion
Asia Sejahtera Mina Tbk
JK:AGAR
Indonesia Rp77.18 Billion
Gateway Mining Ltd
AU:GML
Australia AU$5.39 Million
Nyrada Inc
AU:NYR
Australia AU$548.97K
Waton Financial Limited Ordinary Shares
NASDAQ:WTF
USA $32.93 Million
Multipolar Technology Tbk
JK:MLPT
Indonesia Rp2.73 Trillion
Corpovael S.A.B. de C.V
MX:CADUA
Mexico MX$7.18 Billion
Lanvin Group Holdings Limited
NYSE:LANV
USA $693.10 Million

Liability Composition Analysis (1993–2025)

This chart breaks down Avita Medical Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Avita Medical Ltd's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.57 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -4.39 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.30 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Avita Medical Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Avita Medical Ltd (1993–2025)

The table below shows the annual total liabilities of Avita Medical Ltd from 1993 to 2025.

Year Total Liabilities Change
2025-12-31 $73.04 Million -2.89%
2024-12-31 $75.21 Million +20.18%
2023-12-31 $62.58 Million +362.76%
2022-12-31 $13.52 Million +18.73%
2021-12-31 $11.39 Million +13.22%
2020-12-31 $10.06 Million +103.17%
2019-12-31 $4.95 Million +23.34%
2017-12-31 $4.01 Million +57.68%
2016-12-31 $2.55 Million +45.46%
2015-12-31 $1.75 Million +42.74%
2014-12-31 $1.23 Million -31.35%
2013-12-31 $1.79 Million -27.19%
2012-12-31 $2.45 Million +14.00%
2011-12-31 $2.15 Million +26.54%
2010-12-31 $1.70 Million -56.17%
2009-12-31 $3.88 Million +287.84%
2008-12-31 $1.00 Million -60.72%
2007-12-31 $2.55 Million +138.67%
2006-12-31 $1.07 Million -44.69%
2005-12-31 $1.93 Million +38.67%
2004-12-31 $1.39 Million +172.15%
2003-12-31 $511.27K +63.12%
2002-12-31 $313.44K -40.36%
2001-12-31 $525.57K +1351.65%
2000-12-31 $36.21K -58.71%
1999-12-31 $87.69K +342.35%
1998-12-31 $19.82K +4.35%
1997-12-31 $19.00K -61.80%
1996-12-31 $49.74K -41.90%
1995-12-31 $85.60K -64.52%
1994-12-31 $241.24K -36.85%
1993-12-31 $381.99K --

About Avita Medical Ltd

NASDAQ:RCEL USA Medical Devices
Market Cap
$345.31 Million
Market Cap Rank
#18397 Global
#4296 in USA
Share Price
$11.22
Change (1 day)
+7.37%
52-Week Range
$3.27 - $11.22
All Time High
$55.20
About

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more